The company’s stock price increased by 188%, or 2.9 times. According to MarketWatch, this was made possible by the industry's overall upswing in anticipation of a growth in the need for AI technologies as well as positive business reports that were released on May 1.
Walgreens Boots Alliance stock was the first-half outsider, with a 54% price decline. The pharmacy chain revealed this week that its adjusted earnings for the third quarter of its fiscal year (March–May) fell short of analysts’ projections, and the business revised its outlook.
Furthermore, according to Tim Wentworth, CEO of Walgreens Boots, the corporation will eliminate a sizable number of underperforming pharmacies. There are presently 8,600 pharmacies in the chain.
BofA Securities analysts downgraded their estimate price for Walgreens shares from $22 to $11 and gave the company a "below market" recommendation.
source: bloomberg.com
Walgreens Boots Alliance stock was the first-half outsider, with a 54% price decline. The pharmacy chain revealed this week that its adjusted earnings for the third quarter of its fiscal year (March–May) fell short of analysts’ projections, and the business revised its outlook.
Furthermore, according to Tim Wentworth, CEO of Walgreens Boots, the corporation will eliminate a sizable number of underperforming pharmacies. There are presently 8,600 pharmacies in the chain.
BofA Securities analysts downgraded their estimate price for Walgreens shares from $22 to $11 and gave the company a "below market" recommendation.
source: bloomberg.com